NDC 50488-1001-01 - Terocin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50488-1001
- Requested NDC
- 50488-1001-01
- Package NDCs from labels
- 50488-1001-1, 50488-1001-01
- Manufacturer
- Alexso, Inc
- Effective date
- 2026-10-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Terocin - Alexso, Inc | Alexso, Inc | 2026-10-19 | HUMAN OTC DRUG LABEL |
| Terocin Patch | Preferred Pharmaceuticals, Inc. | 2026-09-30 | HUMAN OTC DRUG LABEL |
| Terocin - ASCLEMED USA INC. | ASCLEMED USA INC. DBA ENOVACHEM | ASCLEMED USA INC. | ASCLEMED USA INC. DBA ENOVACHEM | 2026-05-05 | HUMAN OTC DRUG LABEL |
| Terocin - Quality Care Products LLC | Quality Care Products LLC | 2023-12-21 | HUMAN OTC DRUG LABEL |
| Terocin - A-S Medication Solutions | A-S Medication Solutions | 2021-05-26 | HUMAN OTC DRUG LABEL |
| Terocin Patch | NuCare Pharmaceuticals,Inc. | 2021-02-22 | HUMAN OTC DRUG LABEL |
| Terocin - Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | 2020-12-11 | HUMAN OTC DRUG LABEL |
| NOpioid-LMC - Skya Health, LLC | Skya Health, LLC | 2020-10-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Terocin - A-S Medication Solutions | A-S Medication Solutions | 2020-01-18 | HUMAN OTC DRUG LABEL |
| TEROCIN - DirectRX | DirectRX | 2019-04-23 | HUMAN OTC DRUG LABEL |
| Terocin - medsource pharmaceuticals | medsource pharmaceuticals | 2018-12-20 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50488-1001-1 | Terocin | 2 in 1 BOX | PATCH | 2 | 6 | |
| 50488-1001-1 | Terocin | 5 in 1 POUCH | PATCH | 5 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50488-1001 | TEROCIN (LIDOCAINE, MENTHOL) PATCH [ALEXSO, INC] | 6 | Current NDC, Legacy NDC, 2 package rows | 20241208_100ceb76-8ebe-437b-a8de-37cc76ece9bb.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50488-1001-1 | EA - Each | 50488-1001 | ee8e93c8-555b-43a2-b4b0-b07e6026efed | 1 | 2013-08-02 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Icy Hot Vanishing Scent | MENTHOL | Chattem, Inc. | e2092016-9741-433d-92e6-74bfddadb72c | 2022-09-29 | Warnings | L7T10EIP3A |
| REFRESH OPTIVE | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 7f8d88af-fd3b-4138-af61-f24c59ccebd7 | 2022-09-23 | Warnings | PDC6A3C0OX |
| Beol Cho Long | MENTHOL, GARLIC OIL | sunkyung trading | e939d073-35b0-6a6d-e053-2995a90a0d18 | 2022-09-21 | Warnings | L7T10EIP3A |
| Sterile Water | WATER | Medical Purchasing Solutions, LLC | e90b47e3-9636-b9ee-e053-2a95a90ad48c | 2022-09-19 | Warnings, Adverse reactions | 059QF0KO0R |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | Asclemed USA, Inc. | 2a6b2ad9-307a-4976-98b7-1b96e0408da7 | 2022-09-14 | Warnings, Adverse reactions | 828299 0VE05JYS2P |
| Lidothol | LIDOCAINE HCL, MENTHOL | Asclemed USA, Inc. | 6d7adaca-67dd-4a4b-a85c-d1c2a568dee2 | 2022-09-09 | Warnings, Adverse reactions | L7T10EIP3A |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Asclemed USA, Inc. | f8dec4e2-3151-4a79-b194-a11a57ada0b6 | 2022-09-03 | Warnings, Adverse reactions | 828299 0VE05JYS2P |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | PDC6A3C0OX 6OZP39ZG8H |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Solco Healthcare U.S., LLC | f558863b-ea3f-4e4b-85e9-edb2573e7151 | 2022-08-22 | Warnings, Adverse reactions | 0VE05JYS2P |
| New Terocin | METHYL SALICYLATE, CAPSAICIN, AND MENTHOL | Alexso, Inc | 5dbd5fc0-a27e-4979-aca7-28f73096fd5f | 2022-08-18 | Warnings | L7T10EIP3A |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | Asclemed USA, Inc. | 751f0d33-ceff-40b0-9329-9125f176e06a | 2022-07-29 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Asclemed USA, Inc. | 59945ea1-8136-4014-acd9-cdfe6e11e8da | 2022-07-19 | Warnings, Adverse reactions | 828299 0VE05JYS2P |
| Glycerinum | GLYCERINUM | Hahnemann Laboratories, INC. | e34f8796-85b5-2946-e053-2995a90a251e | 2022-07-08 | PDC6A3C0OX | |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Proficient Rx LP | e3998083-e3db-4052-9b5b-19d7aaa4e658 | 2022-07-01 | Warnings, Adverse reactions | 0VE05JYS2P |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | PDC6A3C0OX 6OZP39ZG8H |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | f42ac50f-0ec5-4713-a4c8-99d972d90bed | 2022-06-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | e71c6c83-d518-496c-b2ab-efd5987e4783 | 2022-06-09 | Warnings, Adverse reactions | 059QF0KO0R |
| Blockaid | LIDOCAINE, TETRACAINE | SofTap Inc | de3af3fa-8acf-2379-e053-2995a90ac77d | 2022-05-06 | Warnings | 98PI200987 |
| Minnerva II | LIDOCAINE, EPINEPHRINE | SofTap Inc | ddd34237-7770-19b3-e053-2995a90af775 | 2022-05-05 | Warnings | 98PI200987 |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Proficient Rx LP | d8112916-28ae-452c-8ec8-a4972e5f549b | 2022-05-02 | Warnings, Adverse reactions | 0VE05JYS2P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.